InflaRx (IFRX) FCF Margin (2023 - 2025)

InflaRx's (IFRX) quarterly FCF Margin came in at 6703.35% in Q4 2025, down 282347703.0% year-on-year from N/an in Q4 2024, and up 174.87% quarter-over-quarter from 8953.06% in Q3 2025.

InflaRx (IFRX) FCF Margin (2023 - 2025) Analysis & Trends

InflaRx has disclosed FCF Margin across 3 years of filings, most recently posting 6703.35% for Q4 2025.

  • FCF Margin for Q4 2025 came in at 6703.35%, down 282347703.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 34706.35% (down 573597.0% YoY), and the FY2025 annual result was 120793.77%, down 9147726.0% from the prior year.
  • FCF Margin came in at 6703.35% for Q4 2025 at InflaRx, up from 8953.06% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 2830180.38% in Q4 2024 to a low of 481294.71% in Q4 2023.
  • The 3-year median for FCF Margin is 19116.12% (2025), against an average of 227661.64%.
  • Across the five-year window, FCF Margin soared 331147509 bps in 2024 and sank 282347703 bps in 2025, its largest moves.
  • InflaRx's FCF Margin stood at 481294.71% in 2023, then jumped by 688 bps to 2830180.38% in 2024, then tumbled by 100 bps to 6703.35% in 2025.
  • The last three FCF Margin figures came in at 6703.35% (Q4 2025), 8953.06% (Q3 2025), and 19116.12% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 43.35%
9 Abivax 94.26 Bn 94.26 Bn - -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -

Historic Data

Download Data
DateValue
Dec 31, 2025 6,703.35%
Sep 30, 2025 -8,953.06%
Jun 30, 2025 -19,116.12%
Mar 31, 2025 -38,863.46%
Dec 31, 2024 2,830,180.38%
Sep 30, 2024 -7,799.75%
Jun 30, 2024 -190,687.89%
Mar 31, 2024 -41,214.02%
Dec 31, 2023 -481,294.71%